BioWorld

Oct. 27, 2005

View Archived Issues

Infectious Disease Firm Idenix Raises $150M In Public Offering

Read More

Cerimon Series A Garners $70M For In-License Push

Read More

Tanox's Stock Surges On HIV Drug Positive Phase II

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

CAT, Abbott Settle Humira Dispute: Abbot Pays $255M

Ending a 2-year-old dispute, Cambridge Antibody Technology plc and Abbott Laboratories reached an agreement concerning Humira royalties payable to CAT under a 1995 deal. (BioWorld Today) Read More

Panel Tackles Eligibility Issue For Biotech Firms, SBIR Grants

Read More